Sandra Schmitz
Overview
Explore the profile of Sandra Schmitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
778
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beyaert S, Loriot A, Machiels J, Schmitz S
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076457
Afatinib-induced tumor and microenvironment modifications in head and neck squamous cell carcinoma were evaluated by spatial transcriptomics in surgical specimens and RNA-sequencing in tumor biopsies of patients included in the...
2.
Van den Bossche V, Vignau J, Vigneron E, Rizzi I, Zaryouh H, Wouters A, et al.
Nat Commun
. 2025 Jan;
16(1):1237.
PMID: 39890801
Anti-epidermal growth factor receptor (EGFR) therapy (cetuximab) shows a limited clinical benefit for patients with locally advanced or recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), due to the frequent...
3.
Schmitz S, Meyer-Feil T
Eur J Phys Rehabil Med
. 2024 Sep;
60(6):1078-1087.
PMID: 39291951
The randomized controlled trial (RCT) is the study design with the greatest potential to maximize internal validity when assessing the effectiveness of medical interventions, making it invaluable for evidence-based medicine....
4.
Seront E, Biard J, Van Damme A, Revencu N, Lengele B, Schmitz S, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(6):595-599.
PMID: 39195878
Sirolimus, by targeting the mammalian target of rapamycin (mTOR) pathway, has demonstrated efficacy on lymphatic malformations (LMs) in adults and neonates. The current hypothesis is that the earlier the lesion...
5.
Beyaert S, Borys A, Baldin P, Dahou H, Magremanne M, Mahy P, et al.
Oral Oncol
. 2024 May;
154:106869.
PMID: 38820890
Objectives: Primary objective was to evaluate the correlation between immune marker expression in baseline tumor biopsies and their respective surgical specimens in squamous cell carcinoma of the oral cavity (OCSCC)....
6.
Zan D, Hoton D, Schmitz S, Onofrj V
Radiol Case Rep
. 2024 Jan;
19(3):886-889.
PMID: 38188945
Mucosal leishmaniosis (ML) is a rare manifestation of leishmaniosis, usually caused by in northeast Brazil and by and in the Mediterranean Europe and Africa. We present the case of a...
7.
Honore N, van der Elst A, Dietz A, van Marcke C, Helaers R, Mendola A, et al.
Eur J Cancer
. 2023 Nov;
195:113372.
PMID: 37913682
Background: Only 15-20% of recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients derive long-term benefit from nivolumab or pembrolizumab. We developed a circulating tumour...
8.
dAbadie P, Michoux N, Duprez T, Schmitz S, Magremanne M, Van Eeckhout P, et al.
Diagnostics (Basel)
. 2023 Aug;
13(16).
PMID: 37627898
Background: In head and neck squamous cell carcinoma (HNSCC), [F]FDG PET/CT is recommended for detecting recurrent disease and in the initial staging for evaluating distant metastases, but its use in...
9.
Beyaert S, Loriot A, Huyghe N, Goebbels R, Mendola A, Govaerts A, et al.
Clin Cancer Res
. 2023 Aug;
29(20):4076-4087.
PMID: 37531234
Purpose: The EORTC-90111-24111 phase II window study evaluated afatinib versus no preoperative treatment in patients with primary squamous cell carcinoma of the head and neck (HNSCC). We investigated afatinib-induced tumor...
10.
Kacar S, Duprez T, Gheysens O, Schmitz S, Van Eeckhout P
J Stomatol Oral Maxillofac Surg
. 2023 May;
125(5S2):101514.
PMID: 37207961
Traumatic Ulcerative Granuloma with Stromal Eosinophilia (TUGSE)/Riga Fede disease is a rare mucosal and submucosal benign reactive inflammatory process, usually involving the tongue. Trauma is believed to be a major...